2nd Annual Gut Week Summit 2020

DESCRIPTION

From 8 to 11 of September 2020, Barcelona, Spain will host The Gut Week Summit 2020. This 2nd Annual event brings together leading scientists, physicians, and senior leaders to explore the potential insights into the Microbiota–Gut–Brain Axis, the Human Microbiome Market that exhibits significant potential in the near future and skin’s microbiome that has the potential to revolutionize the beauty and personal care industry.

 
40+ expert speakers, 40+ case studies demonstrating disease causation of the gut-brain axis and Skin Microbiome

The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Mounting evidence, mostly from rodent studies, suggests that gut microbes help shape normal neural development, brain biochemistry, and behaviour.

The Gut Week Summit 2020 is set to be the “must-attend” meeting for anyone interested in unlocking the potential of the Human Microbiome, and translating it into safe, effective and commercially viable therapeutics.

 

The Gut Week Summit 2020 will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the Human Microbiome Market, GBA in demonstrating disease causation and changing perceptions of bacteria in the Skin Microbiome. Over the last decade, the microbiome has become one of the trendiest areas of biology, and the research has made clear that the microbiome is fundamental to overall health.

 

FEATURED KEY LEARNING POINTS

8-9 SEP 2020

  • The influence of the intestinal microbiome on vaccine responses
  • Effectively understand and manipulate the Gut-Brain Axis
  • Learn about the microbiota and their metabolites and neurotransmitters production
  • Influence of the microbiota on vaccine effectiveness
  • Discover tools and technologies to help investigate the GBA
  • Build predictive pre-clinical models in the gut-brain axis
  • The importance of the gut–brain axis in emotional, behavioral and development disorders
  • Stress related bowel disease: gut-brain axis in IBD and IBS
  • Develop commercially viable therapeutics and nutritional products
  • Probiotics, prebiotics, synbiotics and psychobiotics

10-11 SEP 2020

  • Skin Disease & Microbiome
  • The impact of environment and age on shaping our individual microbiota
  • The skin microbiome: Current perspectives and future challenges
  • Preservative Free-Formulation, Manufacturing and Packing
  • The Skin Microbiome & Big Data
  • Metabolites & Skin Microbiome
  • The Development and Maintenance of the Skin Barrier
  • Human Skin Microbiome: From metagenomes to therapeutics
  • Commercialization of Microbiome-Based Personal Care
  • Regulation considerations for dermatology & cosmetics
  • The applications of L. reuteri DSM 17938 in skin health
  • Commercialising the Therapeutic Potential of The Microbiome in the Field of Metabolic Diseases

COMPANIES ATTENDED IN 2018

  • 4D Pharma Research
  • AB-BIOTICS
  • Amabiotics
  • AMC
  • Amylgen
  • APC Microbiome Ireland
  • Astel Medica
  • AstraZeneca
  • Biocodex
  • Biose
  • NeribiOm
  • Nestlé
  • Bloom Science
  • Chain Biotech
  • Columbia University Medical Center
  • Danone Produits Frais
  • Exden
  • FCS-UFP
  • Finch Therapeutics
  • Greenmed
  • Grenoble Faculty of Medicine & Hospital
  • Holobiome
  • ImmuneBiotech AB
  • Institute of Marine Research
  • Jackson Laboratory
  • Karolinska Institutet
  • Kilee Patchell-Evans Autism
  • Kobiolabs
  • L’Oreal Advanced Research
  • Lallemand Health Solution
  • Lesaffre Human Care
  • LNC Therapeutics
  • Lundbeck
  • Maastricht University
  • MP Healthcare
  • Neuro Paris Saclay
  • Nicklaus Children’s Hospital
  • Northumbria University
  • Novo Nordisk Foundation
  • Örebro University
  • Pharmabiotic Research
  • PiLeJe
  • PRI: Microbiotic Medicinal Products
  • ProDigest
  • Quay Pharmaceuticals
  • Seventure Partners
  • TargEDys
  • Texas Children’s Microbiome
  • UCB Biopharma
  • UCLA
  • University Novi Sad
  • University of Melbourne
  • University of Michigan
  • Winclove Probiotics

WHO SHOULD ATTEND?

  • Scientific Project Leader
  • Head Search & Evaluation Neuroscience
  • Molecular Toxicology
  • Nutrition & Health
  • Laboratory Director
  • Neuroscientist
  • Modeling and Data Specialist
  • Microbiome and Lipid Biology
  • Genome Editing
  • Business Develoment
  • Associate Research Director
  • Strategy & Business
  • IVD Assay Development
  • Safety Risk Lead
  • Skin & Health
  • Preclinical Group Leader
  • Pharmacovigilance
  • Drug Discovery
  • Research Investigator
  • Regulatory Affairs

Professor at McGill University
Chief Executive Officer at The BioCollective
Chief Executive Officer at NeribiOm
Human Microecology Specialist
President for Pen & Tec Consulting
General Partner at Flagship Pioneering
CEO at LNC Therapeutics
Associate Professor at McMaster University
Ph.D. President & Chief Executive Officer at Metabolon
Founder and Chief Science Officer at Viome
Scientific officer at BioGaia
President at European Scientific League for Probiotics - ESLP 
Scientific Director, Advanced Research at L'Oreal
Associate Professor at University of California, Los Angeles
Head of Discovery, Microbiome and Human Health at Chr. Hansen Holding A/S
Chairman of the Board at Lactobio
Instructor at Texas Children's Microbiome Center & Baylor College of Medicine
Associate Professor at University of Gothenburg
Serguei Fetissov
Professor of physiology at Rouen University and co-founder of TargEDys
Co-founder and Chief Executive Officer at S-Biomedic
Shahram Lavasani
Founder and CEO at ImmuneBiotech AB
Professor of Neurogastroenterology at AMC, CoFounder of Gut Research
Rochellys Diaz Heijtz
Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet
Assistant Professor at Eastern Washington University
Head of Unit at PHENOMIN-ICS
Neurologist / CEO at Helsinki University Hospital and NeuroInnovation Ltd.
Postdoctoral Scientist at AgResearch, Palmerston North, New Zealand
Chief Business Officer at EnteroBiotix
Vice President Translational Medicine at Pierre Fabre
Director Institute for Applied Molecular Medicine at Universidad San Pablo Madrid
Co-founder and Director at Progetto Microbioma Italiano
CEO at GeneSurge GmbH
Clinician at National University of Singapore
Academic Package
Early-Bird Rate

4-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Event Certificate

Poster Presentation

€800
Industry Package
Early-Bird Rate

4-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

€1500
Premium Package
Early-Bird Rate

4-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

Airport pick-up/drop-off

2-nights at the Hotel Venue

€2800
Exhibition Package
Best Choice

4-Days Summit

Full-Access to all Sessions

3m2 exhibition space

Logo on the conference website

25% discount for extra ticket

Unique 1-on-1 meetings

Gala Dinner

€3550
Event Details